HemaSphere (Oct 2022)

P062: The efficacy and safety of nivolumab 40 mg therapy versus 3 mg/kg in patients with relapsed and refractory classic Hodgkin lymphoma

  • Liudmila Fedorova,
  • Kirill Lepik,
  • Natalia Mikhailova,
  • Elena Kondakova,
  • Yaroslava Komarova,
  • Polina Kotselyabina,
  • Evgenia Borzenkova,
  • Vadim Baykov,
  • Ivan Moiseev,
  • Alexander Kulagin

DOI
https://doi.org/10.1097/01.HS9.0000890816.89900.95
Journal volume & issue
Vol. 6
pp. 28 – 29

Abstract

Read online

No abstracts available.